Tekla Capital Management LLC Intercept Pharmaceuticals, Inc. Transaction History

Tekla Capital Management LLC

$2.53 Billion
Q2 2023

A detailed history of Tekla Capital Management LLC transactions in Intercept Pharmaceuticals, Inc. stock. As of the latest transaction made, Tekla Capital Management LLC holds 52,067 shares of ICPT stock, worth $0. This represents 0.02% of its overall portfolio holdings.

Number of Shares

52,067

Previous 52,067 -0.0%

Holding current value

Previous $699,000 17.74%

% of portfolio

0.02%

Previous 0.03%

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$12.99 - $20.47 $324,750 - $511,750	-25,000 Reduced 32.44%	52,067 $773,000
Q2 2020 Aug 13, 2020	BUY	$46.7 - $92.04 $1.99 Million - $3.93 Million	42,653 Added 123.94%	77,067 $3.69 Million
Q3 2019 Nov 13, 2019	SELL	$58.69 - $80.46 $1.14 Million - $1.56 Million	-19,443 Reduced 36.1%	34,414 $2.28 Million
Q2 2019 Aug 14, 2019	SELL	$77.77 - $120.68 $421,357 - $653,844	-5,418 Reduced 9.14%	53,857 $4.29 Million
Q1 2019 May 14, 2019	BUY	$91.83 - $120.68 $4.22 Million - $5.54 Million	45,927 Added 344.07%	59,275 $6.63 Million
Q4 2018 Feb 13, 2019	BUY	$85.79 - $126.46 $1.15 Million - $1.69 Million	13,348 New	13,348 $1.35 Million
Q4 2017 Feb 14, 2018	SELL	$58.2 - $72.76 $7.17 Million - $8.96 Million	-123,200 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$57.01 - $118.75 $7.02 Million - $14.6 Million	123,200	123,200 $7.15 Million

Others Institutions Holding ICPT

# of Institutions

Shares Held

1.04M

Call Options Held

30K

Put Options Held

5.9K

View Full List

About INTERCEPT PHARMACEUTICALS, INC.

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

More about ICPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tekla Capital Management LLC with notifications on news.

Account

Tekla Capital Management LLC Intercept Pharmaceuticals, Inc. Transaction History